Patients Need Wound Care.
We Need Your Help.
Now is the time to act to prevent CMS from reducing access to clinically-proven wound care products.
Medicare decision may reduce access to clinically-proven wound care products.
Click the buttons below to send a letter to your elected officials in the US Congress or to tell your wound care story in video form.
BACKGROUND
The Medicare program has historically provided coverage for “skin substitutes” (products derived primarily from donated human tissue) which are clinically-proven in the care of persistent and painful chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure wounds.
On April 25, 2024, all of the nation’s Medicare Administrative Contractors (“MACs”— private companies that administer the government’s Medicare program) issued nearly identical proposed coverage policies eliminating Medicare coverage for the vast majority of skin substitute products and severely restricting use of the few remaining products.
If the proposed policy is finalized, 90% of these effective products that are currently in high use, would no longer be accessible. This will lead to significant shortages of skin substitute products for seniors with serious, painful wounds, which will lead to increased risk of sepsis, amputation and death. Furthermore, the proposed policy would limit skin substitute use to 4 applications, other than in "exceptional" cases, which is outside the current standard of care.
Ready to act to help keep these productS available to the patients who need them?